Multiple Sclerosis Clinical Trial

Laughter Therapy Effects on Mood, Stress and Self-efficacy in People With Neurological Diseases.

Summary

This is a prospective investigation of the effects of Laughter therapy (LT) on perceived stress, self-efficacy, mood and other wellness measures in people with the following neurological conditions: Alzheimer's disease, amyotrophic lateral sclerosis, brain injury, Huntington's Disease, multiple sclerosis, Parkinson's Disease, post-stroke, spinal cord injury.

View Full Description

Full Description

Laughter therapy (LT) has potential benefits in treating illness. It combines laughter with breathing and body exercises to stimulate laughter, both real and artificial, in a group setting. Laughter therapy may help treating illness by strengthening breathing muscles, improving mood, and providing pain and stress relief. EvergreenHealth has presented laughter therapy classes to patients with Parkinson's disease and Multiple sclerosis and other neurological conditions. The therapy will be led by a certified laughter therapist and mental health professional.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Diagnosis based on medical record review of one of the following neurological diseases: Alzheimer's disease, amyotrophic lateral sclerosis, brain injury, Huntington's Disease, Multiple Sclerosis, Parkinson's Disease, Post-Stroke, Spinal Cord Injury.
Medically stable for at least 2 months.
Not participating in Laughter therapy for 30 days prior to screening.

Exclusion Criteria:

Females who are pregnant
Any unstable medical condition
Severe cognitive deficits that would interfere with participation (e.g. unable to follow commands).
Severe abdominal pain, chest pain or back pain.
Abdominal, chest or back surgery within 90 days.
Psychosis or severe mental illness.
Untreated hernia.
Persistent cough.
Advanced hemorrhoids.
Epilepsy.
Uncontrolled Hypertension - SBP >170 or DBP >105.

Study is for people with:

Multiple Sclerosis

Estimated Enrollment:

24

Study ID:

NCT02750982

Recruitment Status:

Completed

Sponsor:

Brown, Theodore R., M.D., MPH

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Evergreen Healthcare
Kirkland Washington, 98034, United States

How clear is this clinincal trial information?

Study is for people with:

Multiple Sclerosis

Estimated Enrollment:

24

Study ID:

NCT02750982

Recruitment Status:

Completed

Sponsor:


Brown, Theodore R., M.D., MPH

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider